Saturday April 04, Barcelona

01.00 - 23.59
WCO-IOF-ESCEO
08.00 - 09.00
NON-SPONSORED SYMPOSIA
08.00 - 09.00
AVAILABLE INDUSTRY BREAKFAST SYMPOSIUM
08.00 - 09.00
AVAILABLE INDUSTRY BREAKFAST SYMPOSIUM
08.00 - 09.00
Radiofrequency Echographic Multi-Spectrometry for the in-Vivo Assessment of Bone Strength: State of the Art: outcomes of an experts consensus meeting organized under the auspices of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and under the auspices of the International Osteoporosis Foundation (IOF).
Chairpersons: ‣ Maria Luisa Brandi, ‣ Adolfo Diez‑Perez
‣ Introduction Hans Peter Dimai
‣ Current role of bone strength in the assessment of fracture risk Thierry Thomas
‣ Radiofrequency echographic multi-spectrometry: Basic principles and clinical validation Maria Luisa Brandi
‣ Discussion Stefano Gonnelli
Panel: ‣ Jaime Branco, ‣ Maria Luisa Brandi, ‣ Olivier Bruyère, ‣ Sergio Casciaro, ‣ Loredana Cavalli, ‣ Bernard Cortet, ‣ Adolfo Diez‑Perez, ‣ Hans Peter Dimai, ‣ Stefano Gonnelli, ‣ Philippe Halbout, ‣ John A. Kanis, ‣ Jean‑Marc Kaufman, ‣ Médéa Locquet, ‣ Radmila Matijevic, ‣ Jean‑Yves Reginster, ‣ René Rizzoli, ‣ Thierry Thomas
08.00 - 09.00
Impact of whole dairy matrix on musculoskeletal health and aging. Outcomes of a workshop organized under the auspices of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO).
Chairperson: ‣ Arne Astrup
‣ Introduction Arne Astrup
‣ The concept of food matrix compared to single nutrients Ian Givens
‣ Importance of dairy matrix for skeletal health Sandra Iuliano
‣ Discussion Yannis Manios
‣ Conclusion and wrap up Arne Astrup
Panel: ‣ Arne Astrup, ‣ Nina Geiker, ‣ Ian Givens, ‣ Sandra Iuliano, ‣ Jean‑Michel Lecerf, ‣ Yannis Manios, ‣ Christian Molgaard, ‣ Jean‑Yves Reginster, ‣ René Rizzoli, ‣ Luc J. C. van Loon
08.00 - 09.00
EUGMS-ESCEO-IOF Joint Session "Avoiding medication related harm when treating osteoarticular disease in older people"
Chairperson: ‣ Finbarr Martin
‣ Introduction: Medication related harm Finbarr Martin
‣ Drugs that may harm your older patients: potentially inappropriate prescribing Mirko Petrovic
‣ Potential problems in the use of drugs for osteoarticular conditions in old age Antonio Cherubini
09.00 - 10.30
SCIENTIFIC SESSION IV
Chairpersons: ‣ Elaine M. Dennison, ‣ Olivier Bruyère
09.00
Plenary Lecture 5
‣ Sarcopenia : new definitions and clinical implications Alfonso Cruz Jentoft
09.30
Oral communication selected from abstracts
10.20
Presentation of the ESCEO-IOF Pierre Meunier Young Scientist Award
‣ John A. Kanis
10.30 - 12.00
SCIENTIFIC SESSION V
Chairpersons: ‣ Adolfo Diez‑Perez, ‣ Manju Chandran
10.30
Presentation of the IOF Medal of Achievement
‣ Nicholas Harvey
10.40
Plenary Lecture 6
‣ How to reduce falls in oldest people ? Heike A. Bischoff‑Ferrari
11.10
Oral communication selected from abstracts
14.00 - 15.00
Poster Viewing Session II
14.00 - 15.00
Oral presentation of selected posters
14.00 - 15.00
MEET-THE-EXPERT SESSIONS
Menopausal hormone therapy in 2020
‣ Santiago Palacios
Risks and benefits of calcium supplementation
‣ Nicholas Harvey
Physical therapy for osteoarthritis
‣ Olivier Bruyère
Local bone treatments
‣ Maria Luisa Brandi
Milk, yogurt, cheese and bone: Friends or foes ?
‣ Sandra Iuliano
Structural determinants and purity differ in food supplement respect to CS based pharma products: effect on biological features (supported by an Unrestricted Educational Grant from Ibsa)
‣ Chiara Schiraldi
14.00 - 15.00
Algorithm for the use of biochemical markers of bone turnover in the diagnosis and follow-up of treatment for osteoporosis: outcomes of an ESCEO experts consensus meeting organized under the auspices of the World Health Organization Collaborating Center for Public Health Aspects of Musculoskeletal Health and Ageing
Chairpersons: ‣ Etienne Cavalier, ‣ Adolfo Diez‑Perez
‣ Introduction John A. Kanis
‣ Clinical application of bone turnover markers in post-menopausal osteoporosis Mattias Lorentzon
‣ Algorithm for the assessment of anti-osteoporosis treatments by bone turnover markers Eugene McCloskey
‣ Discussion Markus Herrmann
Panel: ‣ Jaime Branco, ‣ Maria Luisa Brandi, ‣ Olivier Bruyère, ‣ Etienne Cavalier, ‣ Roland D. Chapurlat, ‣ Cyrus Cooper, ‣ Bernard Cortet, ‣ Adolfo Diez‑Perez, ‣ Serge Ferrari, ‣ Andrea Ildiko Gasparik, ‣ Markus Herrmann, ‣ Niklas Rye Jorgensen, ‣ John A. Kanis, ‣ Jean‑Marc Kaufman, ‣ Andrea Laslop, ‣ Médéa Locquet, ‣ Mattias Lorentzon, ‣ Radmila Matijevic, ‣ Eugene McCloskey, ‣ Salvatore Minisola, ‣ Richard Pikner, ‣ Jean‑Yves Reginster, ‣ René Rizzoli, ‣ Pawel Szulc
15.00 - 17.00
SCIENTIFIC SESSION VI
Chairpersons: ‣ Charlotte Beaudart, ‣ E. M. Curtis
15.00
Plenary Lecture 7
‣ What did we learn from the recent large vitamin D trials Bess Dawson‑Hughes
15.30
Oral communication selected from abstracts
16.30
Plenary Lecture 8
‣ New pharmacological treatments for osteoarthritis Elaine M. Dennison
15.00 - 16.45
Committee of Scientific Advisors Special Session: Technology, comorbidity and rehabilitation in bone health- highlights from the IOF Committee of Scientific Advisors 2020
Chairpersons: ‣ Nicholas Harvey, ‣ Serge Ferrari
‣ Novel technologies for the non-invasive evaluation of femoral strength in fracture risk assessment Mary Bouxsein
‣ Optimisation of bone health in chronic kidney disease: EUROD-IOF consensus statement Kassim Javaid
‣ Maximising function through post-fracture rehabilitation Olivier Bruyère
17.00 - 18.30
AVAILABLE INDUSTRY SATELLITE SYMPOSIUM